Bioadaptives Stock Net Income
| BDPT Stock | USD 0.02 0 19.10% |
As of the 12th of February 2026, BioAdaptives shows the Standard Deviation of 16.14, risk adjusted performance of (0.01), and Mean Deviation of 9.65. BioAdaptives technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Analyzing historical trends in various income statement and balance sheet accounts from BioAdaptives' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BioAdaptives' valuation are summarized below:BioAdaptives does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. BioAdaptives |
BioAdaptives 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioAdaptives' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioAdaptives.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in BioAdaptives on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding BioAdaptives or generate 0.0% return on investment in BioAdaptives over 90 days. BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals More
BioAdaptives Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioAdaptives' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioAdaptives upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 95.45 | |||
| Value At Risk | (31.03) | |||
| Potential Upside | 25.0 |
BioAdaptives Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioAdaptives' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioAdaptives' standard deviation. In reality, there are many statistical measures that can use BioAdaptives historical prices to predict the future BioAdaptives' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (2.21) | |||
| Treynor Ratio | 1.18 |
BioAdaptives February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 1.19 | |||
| Mean Deviation | 9.65 | |||
| Coefficient Of Variation | (5,397) | |||
| Standard Deviation | 16.14 | |||
| Variance | 260.52 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (2.21) | |||
| Treynor Ratio | 1.18 | |||
| Maximum Drawdown | 95.45 | |||
| Value At Risk | (31.03) | |||
| Potential Upside | 25.0 | |||
| Skewness | 0.8955 | |||
| Kurtosis | 3.77 |
BioAdaptives Backtested Returns
BioAdaptives appears to be out of control, given 3 months investment horizon. BioAdaptives secures Sharpe Ratio (or Efficiency) of 0.0198, which signifies that the company had a 0.0198 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for BioAdaptives, which you can use to evaluate the volatility of the firm. Please makes use of BioAdaptives' Risk Adjusted Performance of (0.01), mean deviation of 9.65, and Standard Deviation of 16.14 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BioAdaptives holds a performance score of 1. The firm shows a Beta (market volatility) of -0.26, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning BioAdaptives are expected to decrease at a much lower rate. During the bear market, BioAdaptives is likely to outperform the market. Please check BioAdaptives' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to make a quick decision on whether BioAdaptives' price patterns will revert.
Auto-correlation | 0.03 |
Virtually no predictability
BioAdaptives has virtually no predictability. Overlapping area represents the amount of predictability between BioAdaptives time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioAdaptives price movement. The serial correlation of 0.03 indicates that only 3.0% of current BioAdaptives price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.03 | |
| Spearman Rank Test | 0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, BioAdaptives reported net income of (1.05 Million). This is 100.09% lower than that of the Consumer Defensive sector and 98.93% lower than that of the Packaged Foods industry. The net income for all United States stocks is 100.18% higher than that of the company.
BioAdaptives Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioAdaptives' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BioAdaptives could also be used in its relative valuation, which is a method of valuing BioAdaptives by comparing valuation metrics of similar companies.BioAdaptives is currently under evaluation in net income category among its peers.
BioAdaptives Fundamentals
| Return On Asset | -3.43 | |||
| Operating Margin | (33.58) % | |||
| Current Valuation | 544.74 K | |||
| Shares Outstanding | 160.49 M | |||
| Shares Owned By Insiders | 7.39 % | |||
| Price To Earning | (14.28) X | |||
| Price To Sales | 7.53 X | |||
| Revenue | 19.78 K | |||
| Gross Profit | 10.11 K | |||
| EBITDA | (643.76 K) | |||
| Net Income | (1.05 M) | |||
| Cash And Equivalents | 49.58 K | |||
| Total Debt | 450.26 K | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (158.65 K) | |||
| Earnings Per Share | (0.02) X | |||
| Beta | -0.29 | |||
| Market Capitalization | 144.44 K | |||
| Total Asset | 148.59 K | |||
| Retained Earnings | (2.96 M) | |||
| Working Capital | (160 K) | |||
| Current Asset | 156 K | |||
| Current Liabilities | 316 K | |||
| Z Score | -41.0 | |||
| Net Asset | 148.59 K |
About BioAdaptives Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioAdaptives's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioAdaptives using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioAdaptives based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioAdaptives Pink Sheet Analysis
When running BioAdaptives' price analysis, check to measure BioAdaptives' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAdaptives is operating at the current time. Most of BioAdaptives' value examination focuses on studying past and present price action to predict the probability of BioAdaptives' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAdaptives' price. Additionally, you may evaluate how the addition of BioAdaptives to your portfolios can decrease your overall portfolio volatility.